Skip to content
DataLookout
Menu

Tango Therapeutics, Inc. clinical trial pipeline

Get alerts when Tango Therapeutics, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor: TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors Study completion pushed from Sep 2026 to Nov 2026 Tango Therapeutics, Inc.Phase 1/2 NCT05887492
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-27 NCT07897734 TNG462-C103: Study to Evaluate the Safety, Tolerability, and Antitumor Activity of… Phase 1/2 Not Yet Recruiting

Active trials by phase

Phase 1/2
5

Disease areas by active trials

Get alerts when Tango Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free